RENOIR Trial — RSVpreF Vaccine Efficacy over Two Seasons

Respiratory syncytial virus remains a serious cause of illness in older persons. In this follow-up report of the RENOIR trial, efficacy of the RSVpreF vaccine is assessed over a second season.

​   The New England Journal of Medicine: Search Results in Infectious Disease